EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Socioeconomic differences in use of antiseizure medication in pregnancies with maternal epilepsy: A population‐based study from Nordic universal health care systems

Maarit K Leinonen iD, Jannicke Igland, Julie Werenberg Dreier, Silje Alvestad, Jacqueline M Cohen, Nils Erik Gilhus, Mika Gissler, Yuelian Sun, Torbjörn Tomson iD, Helga Zoega, Håkon M Vegrim iD, Jakob Christensen iD und 1 weitere

Epilepsia · 2024-08 · 65 (8) · 2397-2411

DOI: 10.1111/epi.18022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 28.05.2024. Verfasst von Maarit K Leinonen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Finnish Institute for Health and Welfare, Knowledge Brokers, Helsinki, Finland. Hauptthemen laut MEDLINE: Epilepsy, Anticonvulsants, Pregnancy Complications. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Norges Forskningsråd, NordForsk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Research points to disparities in disease burden and access to medical care in epilepsy. We studied the association between socioeconomic status (SES) and antiseizure medication (ASM) use in pregnancies with maternal epilepsy.

Methods

We conducted a cross‐sectional study consisting of 21 130 pregnancies with maternal epilepsy identified from Nordic registers during 2006–2017. SES indicators included cohabitation status, migrant background, educational attainment, and household income. Main outcomes were the proportion and patterns of ASM use from 90 days before pregnancy to birth. We applied multiple imputation to handle SES variables with 2%–4% missingness. We estimated adjusted risk ratios (aRRs) and 95% confidence intervals (CIs) using modified Poisson regression with the highest SES category as reference.

Results

Mothers with the highest education and the highest income quintile used ASMs least frequently (56% and 53%, respectively). We observed increased risks of ASM discontinuation prior to or during the first trimester for low SES. The risk estimates varied depending on the SES indicator from aRR = 1.27 for low income (95% CI: 1.03–1.57) to aRR = 1.66 for low education (95% CI: 1.30–2.13). Migrant background was associated with ASM initiation after the first trimester (aRR 2.17; 95% CI 1.88–2.52). Low education was associated with the use of valproate during pregnancy in monotherapy (aRR 1.70; 95% CI 1.29–2.24) and in polytherapy (aRR 2.65; 95% CI 1.66–4.21). Low education was also associated with a 37% to 39% increased risk of switching from one ASM to another depending on the ASM used. For the other SES indicators, aRRs of switching varied from 1.16 (foreign origin; 95% CI 1.08–1.26) to 1.26 (not married or cohabiting; 95% CI 1.17–1.36). Significance Low SES was associated with riskier patterns of ASM use: discontinuation, late initiation, and switching during pregnancy. These findings may reflect unplanned pregnancies, disparities in access to preconception counseling, and suboptimal care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyAnticonvulsantsPregnancy ComplicationsHumansFemalePregnancyAdultCross-Sectional StudiesSocioeconomic FactorsScandinavian and Nordic CountriesYoung AdultSocial ClassRegistries

Stichwörter der Autor:innen

access to careantiepileptic drugsdisparitiespregnancysocioeconomic factors

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Finnish Institute for Health and Welfare, Knowledge Brokers, Helsinki, Finland.
  • Department of Neurology, Aarhus University Hospital, Affiliated Member of the European Reference Network EpiCARE, Aarhus, Denmark.
  • Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
  • Department of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
  • National Centre for Register-Based Research, Business and Social Sciences, Aarhus University, Aarhus, Denmark.
  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.

ORCID-Profile: Maarit K Leinonen, Torbjörn Tomson, Håkon M Vegrim, Jakob Christensen, Marte-Helene Bjørk

Förderung

  • Norges Forskningsråd
  • NordForsk

Zitieren

APA

Leinonen, M. K., Igland, J., Dreier, J. W., Alvestad, S., Cohen, J. M., Gilhus, N. E., Gissler, M., Sun, Y., Tomson, T., Zoega, H., Vegrim, H. M., Christensen, J., & Bjørk, M. H. (2024). Socioeconomic differences in use of antiseizure medication in pregnancies with maternal epilepsy: A population‐based study from Nordic universal health care systems. Epilepsia, 65(8), 2397-2411. https://doi.org/10.1111/epi.18022

Vancouver

Leinonen MK, Igland J, Dreier JW, Alvestad S, Cohen JM, Gilhus NE, et al. Socioeconomic differences in use of antiseizure medication in pregnancies with maternal epilepsy: A population‐based study from Nordic universal health care systems. Epilepsia. 2024;65(8):2397-2411. doi:10.1111/epi.18022

BibTeX
@article{Leinonen2024,
  author = {Leinonen, Maarit K and Igland, Jannicke and Dreier, Julie Werenberg and Alvestad, Silje and Cohen, Jacqueline M and Gilhus, Nils Erik and Gissler, Mika and Sun, Yuelian and Tomson, Torbjörn and Zoega, Helga and Vegrim, Håkon M and Christensen, Jakob and Bjørk, Marte-Helene},
  title = {Socioeconomic differences in use of antiseizure medication in pregnancies with maternal epilepsy: A population‐based study from Nordic universal health care systems},
  journal = {Epilepsia},
  year = {2024},
  volume = {65},
  number = {8},
  pages = {2397--2411},
  doi = {10.1111/epi.18022}
}
Kostenlos starten →